Literature DB >> 18474401

Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.

Nicole Martin-Moutot1, Luc De Haro, Michael Seagar.   

Abstract

To determine whether titers of anti-P/Q type and anti-N type calcium channel antibodies provide distinct information, both types of assay were performed during follow-up of 7 patients with Lambert-Eaton myasthenic syndrome (LEMS). In 4 patients with both antibody responses, titers evolved independently and often in an inverse relationship. Two patients with squamous cell lung carcinoma (SqCLC) produced anti-N type channel antibodies, but no detectable anti-P/Q channel responses. These results suggest that anti-N channel autoantibodies constitute an immune response distinct from the anti-P/Q type channel specificity and can also correlate with clinical evolution. Consequently combined assays may provide more comprehensive information during follow-up of LEMS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474401     DOI: 10.1016/j.jneuroim.2008.04.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Large granular lymphocytic leukemia associated with Lambert-Eaton Myasthenic Syndrome: A case report.

Authors:  Richard Lemal; Carine Chaleteix; Patrice Minard; Corinne Roche; Jacques-Olivier Bay; Olivier Tournilhac; Thierry Lamy
Journal:  Leuk Res Rep       Date:  2013-04-02

Review 3.  The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma.

Authors:  Sarah Ew Briggs; Paul Gozzard; Denis C Talbot
Journal:  Immunotargets Ther       Date:  2013-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.